Products

Viz.ai
Viz.ai
Neurology AI
Viz.ai closes the gaps between patients, clinicians, and life-saving treatments with its leading-edge, AI-powered care coordination platform — driven by over 50 advanced, FDA-cleared algorithms.
Viz ICH
Viz.ai
Neurology AI
Viz ICH by Viz.ai is an AI-powered software for detecting and triaging intracranial hemorrhage (ICH), providing automated quantification of hemorrhage volume, lateral ventricle dimensions, and midline shift to accelerate diagnosis and care coordination.
Viz HDS
Viz.ai
Neurology AI
Viz HDS (Viz ICH+) is an FDA-cleared AI-powered solution by Viz.ai that automates the identification, labeling, and quantification of intracranial hyperdensities, lateral ventricles, and midline shift on non-contrast CT images, enhancing the speed and accuracy of diagnosis and care coordination for conditions like intracranial hemorrhage.

See all 12 products →

About Viz.ai

Viz.ai is a leading healthcare artificial intelligence company dedicated to transforming patient care through intelligent software and AI-powered care coordination. Their mission is to accelerate diagnosis and treatment, ultimately improving access to life-saving therapies and patient outcomes. The Viz.ai One platform leverages over 50 FDA-cleared AI algorithms to analyze multimodal clinical data, including CT scans, EKGs, and echocardiograms, delivering real-time insights and automated assessments.

For physicians, Viz.ai’s platform integrates seamlessly into clinical workflows, providing critical diagnostic data at decision-making moments. It is designed to connect multidisciplinary care teams, such as radiologists, emergency physicians, and specialists, enabling faster communication and coordinated responses for time-critical conditions. The company’s solutions have demonstrated real-world impact by reducing systemic delays in care, increasing diagnostic rates, and enhancing workflows across health systems, covering over 230 million lives across nearly 2,000 hospitals in the U.S. and Europe.

The platform offers specialized suites for various medical disciplines, including neurovascular, cardiovascular, vascular, oncology, trauma, and radiology. By automating the detection and triage of complex medical conditions from imaging data, Viz.ai empowers clinicians to identify urgent cases more rapidly, streamline communication, and ensure patients receive appropriate and timely treatment, thereby improving clinical efficiency and patient care.

Focus Areas

AI-powered disease detection care coordination workflow optimization stroke (Large Vessel Occlusion Intracerebral Hemorrhage Subdural Hemorrhage Cerebral Aneurysm) cardiology (Hypertrophic Cardiomyopathy Pulmonary Embolism Aortic Disease Cardiac Amyloidosis) trauma radiology life sciences abdominal aortic aneurysm

Business Intelligence

Key InvestorsTiger Global, Insight Partners, Scale Ventures, Kleiner Perkins, Threshold, GV (Google Ventures), Sozo Ventures, CRV, Susa, Greenoaks, Innovation Endeavors, HCA Healthcare, Canadian Imperial Bank of Commerce, Pear VC, Danhua Capital (DHVC)
PartnershipsMicrosoft, Salesforce, Sanofi, Regeneron, Novartis, Guardant Health, Cleerly, Addario Lung Cancer Medical Institute, Bristol Myers Squibb, Alnylam Pharmaceuticals, Medtronic, Johnson & Johnson
TechnologyAI-powered care coordination platform, multimodal intelligence platform (Viz.ai One®), cloud-native, utilizes deep learning and machine learning, unifies imaging, EHR, and unstructured clinical data in real time, integrates with PACS and radiology worklists, uses AWS for infrastructure
FDA Clearances50+ cleared products (estimated)

What Physicians Need to Know

Stroke (Neurovascular)
Viz.ai offers AI-powered solutions for the rapid detection and triage of suspected Large Vessel Occlusion (LVO) strokes, Intracerebral Hemorrhage (ICH), Subdural Hemorrhage (SDH), and Cerebral Aneurysms. The platform provides real-time alerts and advanced image analysis, including 3D CT angiography, to accelerate diagnosis and treatment decisions. It has been shown to significantly reduce door-to-groin and door-to-recanalization times, improving patient outcomes.
Cardiology
Viz.ai's cardiology suite includes AI-powered disease detection for Hypertrophic Cardiomyopathy (HCM) via ECG analysis, Pulmonary Embolism (PE), Aortic Disease (including Aortic Dissection and Abdominal Aortic Aneurysm), and Cardiac Amyloidosis (ATTR-CM) via echocardiogram AI. The Viz ACS solution helps accelerate treatment for Acute Coronary Syndrome by providing real-time access to ECGs and patient data, reducing unnecessary cath lab activations.
Trauma
Viz Trauma delivers AI-powered solutions to increase diagnostic confidence, collaboration, and trauma care team autonomy. It provides a mobile and web high-fidelity image viewer supporting various modalities (CT, CTA, MRI, X-Ray, EKG, ultrasound) and HIPAA-compliant communication tools to streamline workflow and expedite decision-making and treatments, helping meet new ACS trauma center standards.
Radiology
The Viz Radiology Suite is designed to accelerate patient diagnosis and treatment by offering AI-powered notifications directly to the worklist, prioritizing critical findings, and integrating with PACS and EHR systems. It provides radiologists with a mobile and web image viewer, enhancing efficiency and supporting informed decisions.
Life Sciences
Viz.ai partners with pharmaceutical and medical device companies to develop customized, AI-powered care pathways for treatable diseases. These solutions aim to find and activate more underdiagnosed patients, streamline workflows by connecting the right information to the right specialist, and accelerate access to treatment.
Abdominal Aortic Aneurysm (AAA)
Viz.ai has an FDA-cleared AI algorithm (Viz AAA) for the detection and triage of suspected abdominal aortic aneurysms from CT angiography (CTA) scans. This is part of the Viz Aortic Module, designed to accelerate treatment decisions for all aortic pathology by automatically identifying subtle changes in the aorta.
Physician Tip

For physicians, Viz.ai offers a significant advantage by accelerating the speed of diagnosis and treatment, particularly in time-sensitive conditions like stroke and acute coronary syndrome, potentially saving lives and improving patient outcomes. The AI acts as a 'second pair of eyes,' increasing diagnostic confidence and helping prioritize critical cases, reducing cognitive load and burnout. The integrated communication platform streamlines multidisciplinary team coordination, allowing for immediate access to imaging and patient information, and facilitating faster, more informed decision-making from anywhere. This leads to more efficient workflows, reduced unnecessary transfers, and improved adherence to clinical guidelines.

Viz.ai One is designed for seamless integration with existing hospital infrastructure, including Picture Archiving and Communication Systems (PACS) and Electronic Health Record (EHR) systems. This interoperability allows for real-time data exchange, bringing AI-powered insights and relevant patient context directly into clinical workflows with minimal IT effort, thereby enhancing a unified experience for healthcare systems.

Products by Viz.ai

12 products in the directory

Viz.ai
Viz.ai
Neurology AI
Viz.ai closes the gaps between patients, clinicians, and life-saving treatments with its leading-edge, AI-powered care coordination platform — driven by over 50 advanced, FDA-cleared algorithms.
Viz ICH
Viz.ai
Neurology AI
Viz ICH by Viz.ai is an AI-powered software for detecting and triaging intracranial hemorrhage (ICH), providing automated quantification of hemorrhage volume, lateral ventricle dimensions, and midline shift to accelerate diagnosis and care coordination.
Viz HDS
Viz.ai
Neurology AI
Viz HDS (Viz ICH+) is an FDA-cleared AI-powered solution by Viz.ai that automates the identification, labeling, and quantification of intracranial hyperdensities, lateral ventricles, and midline shift on non-contrast CT images, enhancing the speed and accuracy of diagnosis and care coordination for conditions like intracranial hemorrhage.
ContaCT
Viz.AI
Neurology AI
Viz.ai is a pioneering AI-powered care coordination platform that accelerates disease detection and streamlines clinical workflows. With multiple FDA clearances, including the initial Viz.AI Contact application for stroke, it helps ensure patients receive timely treatment across over 1,700 hospitals globally.
Viz CTP
Viz.ai
Clinical Decision Support & Reference
Viz.ai is a pioneer in AI-powered disease detection and intelligent care coordination, leveraging over 50 FDA-cleared algorithms to analyze medical imaging and streamline clinical workflows for faster diagnosis and treatment.
Viz SDH
Viz.ai
Neurology AI
AI-powered Viz SUBDURAL (SDH) automatically detects subdural hemorrhage, enables effective triage and optimal care.
Viz RV/LV
Viz.ai
Cardiology AI
Viz RV/LV by Viz.ai is an FDA-cleared AI algorithm that automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution.
Viz LVO ContaCT
Viz.ai
Neurology AI
Viz LVO ContaCT by Viz.ai is an FDA-cleared AI solution for rapid detection and notification of suspected large vessel occlusion (LVO) strokes from CT angiogram images. It streamlines neurovascular care coordination, enabling faster treatment decisions and improved patient outcomes.
Viz HCM
Viz.ai
Cardiology AI
Viz HCM is an FDA-cleared AI tool by Viz.ai that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time.
Viz AAA
Viz.ai
Cardiology AI
Viz AAA is the first FDA-cleared AI-powered solution by Viz.ai for the detection and triage of suspected Abdominal Aortic Aneurysm (AAA) from CT angiography scans, designed to accelerate diagnosis and care coordination.
Viz Subdural+
Viz.ai
Neurology AI
Viz Subdural+ is an AI-powered tool by Viz.ai that automates the detection, labeling, and quantification of subdural hemorrhages on non-contrast CT scans, streamlining diagnosis and care coordination for neurovascular conditions.
Viz ANEURYSM
Viz.ai
Neurology AI
Viz ANEURYSM is an FDA-cleared AI-powered solution by Viz.ai that auto-detects suspected cerebral aneurysms in CT angiograms (CTAs), streamlining neurovascular care coordination and facilitating timely patient management.

What the Web Says

Viz.ai is a highly-rated company specializing in AI-powered disease detection and care coordination, particularly for stroke and cardiovascular conditions. Their platform aims to reduce time to treatment and improve patient outcomes by providing real-time insights and alerts to medical specialists. The company has a strong presence in nearly 2,000 hospitals across the U.S. and Europe and has received positive feedback for its impact on clinical workflows. Employer reviews generally indicate a positive work culture with a strong mission, though some concerns exist regarding compensation and workload in certain departments.

Overall: Positive

Strengths

  • Significantly reduces time-to-treatment for critical conditions like stroke and pulmonary embolism.
  • Provides real-time alerts and intelligent care coordination, improving communication among medical teams.
  • Widely deployed and integrated into existing hospital workflows, with positive feedback from physicians.
  • Strong company culture with a motivating mission to improve patient lives.
  • Supportive and collaborative team environment with intelligent and hardworking colleagues.
  • Offers generous PTO and a remote work program.

Limitations

  • Enterprise-only pricing makes it inaccessible to individual physicians.
  • Potential for 'alert fatigue' among on-call specialists due to constant notifications.
  • Not a general clinical decision support tool; specialized for imaging triage and care coordination.
  • Some employees report compensation being less than comparable competitors and difficulty in receiving raises.
  • Issues with SSO and user management have been reported, requiring tweaks and follow-ups with vendor support.
  • Some employees feel undervalued, particularly in customer success, due to workload and compensation structure.

Based on reviews from: Clinical AI Report, G2, Comparably, CREAITIQUE, SoftFinders, FeaturedCustomers, Indeed.com, Reddit, Stock Titan

Last updated: 2026-07-19

Videos

News, demos, and interviews about Viz.ai.

Loading videos...

Videos load interactively. If none appear, search YouTube for Viz.ai →

View all on YouTube

Press & Coverage

Viz.ai
Viz.ai Launches Viz Pulmonary Suite, the First Comprehensive AI-Powered Solution Dedicated to Pulmonary Care Delivery
Viz.ai launched its Viz Pulmonary Suite, an AI-powered solution to streamline care for pulmonary conditions, showing early results of reduced time to treatment and improved patient outcomes.
2026-05
Viz.ai
Viz.ai Announces Strategic Collaboration to Expand Access to AI-Powered Subdural Hemorrhage Care
Viz.ai announced a strategic collaboration with Johnson & Johnson to expand access to its AI-powered Subdural Hemorrhage software solution, aiming to improve detection and care pathways for chronic subdural hematoma.
2026-04
Viz.ai
Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration
Viz.ai partnered with Cortechs.ai to expand into neurodegenerative diseases, tackling conditions like multiple sclerosis across Viz.ai's health system network.
2026-07
Viz.ai
Viz.ai Achieves ISO/IEC 42001 Certification, Setting the Standard for Agentic AI in Healthcare
Viz.ai received ISO/IEC 42001 certification, validating its enterprise-grade AI governance framework for safe and scalable agentic clinical workflows in healthcare.
2026-05
Viz.ai
Viz.ai Study Demonstrates 44% Reduction in Interfacility Stroke Transfer Times
New clinical data presented at the International Stroke Conference 2026 showed a 44% reduction in door-in-door-out time for large vessel occlusion stroke patients in regional care settings due to the Viz.ai platform.
2026-03
Viz.ai
Three New Studies Show Viz.ai's Cardio Suite Speeds Detection of Cardiac Disease and Improves Patient Follow-Up
Three abstracts presented at ACC.26 highlighted the impact of Viz HCM, an AI-powered ECG analysis solution, on earlier detection of hypertrophic cardiomyopathy and improved patient follow-up.
2026-03
Viz.ai
Viz.ai Launches Viz Agent Studio Enabling Health Systems to Build and Scale Their Own AI Care Pathways
Viz.ai launched Viz Agent Studio, a new capability within its Viz Oneu00ae Platform, allowing health systems to create and scale their own AI Care Pathways using natural language.
2026-03
PMC (PubMed Central)
Revolutionizing Intracranial Hemorrhage Diagnosis: A Retrospective Analytical Study of Viz.ai ICH for Enhanced Diagnostic Accuracy
A retrospective study indicated that Viz.ai ICH can detect intracranial hemorrhage with promising performance, showing 85% sensitivity and 98% specificity, particularly for larger volume/size hemorrhages.
2024-08

Frequently Asked Questions

Viz.ai's AI platform utilizes over 50 FDA-cleared algorithms to analyze medical imaging data, providing real-time insights and automated assessments to accelerate disease detection. This rapid identification and streamlined workflow lead to faster diagnoses, quicker treatment decisions, and ultimately improved patient outcomes in time-sensitive conditions like stroke and intracerebral hemorrhage.
Beyond stroke (including Large Vessel Occlusion, Intracerebral Hemorrhage, Subdural Hemorrhage, and Cerebral Aneurysm), Viz.ai's platform extends to cardiology with modules for Hypertrophic Cardiomyopathy (HCM), Pulmonary Embolism (PE), Aortic Disease (dissection, aneurysm), Acute Coronary Syndrome (ACS), and Cardiac Amyloidosis. Additionally, the Viz Trauma Suite is designed to support trauma care providers by streamlining communications and improving patient outcomes in accordance with trauma center guidelines.
Viz.ai's platform, Viz.ai One, acts as an intelligent care coordination solution that connects multidisciplinary teams through real-time AI-powered alerts and a HIPAA-compliant mobile image viewer. This enables specialists to access critical patient information and communicate seamlessly from anywhere, significantly reducing time to treatment and optimizing clinical workflows.
Viz.ai offers the Viz.ai One enterprise platform, which includes specialized suites like Viz Neuro, Viz Cardio, Viz Vascular, Viz Trauma, and Viz Radiology, each with multiple AI-powered modules for specific conditions. These solutions are designed for seamless integration with existing hospital Picture Archiving and Communication Systems (PACS), Electronic Health Records (EHRs), and cloud environments to provide system-wide intelligence and workflow gains.
Viz.ai is committed to data security and privacy, evidenced by its adherence to HIPAA and GDPR regulations, and has successfully completed the SOC 2 Type II + HIPAA audit for four consecutive years. The company's AI algorithms are FDA-cleared for diagnostic tools, ensuring regulatory compliance and responsible AI deployment.
Viz.ai primarily operates on a subscription model, charging hospitals an annual fee that typically varies based on the number of algorithms utilized and the size of the patient population served. For support, Viz.ai provides dedicated 24/7 on-call clinical specialists, implementation experts, and a customer success team to assist users.
Viz.ai's long-term vision is to radically transform healthcare by increasing access to life-saving treatments through AI-powered care coordination, aiming for enterprise-wide solutions across specialties. As a leader in healthcare AI, deployed in nearly 2,000 hospitals and achieving profitability in its healthcare business in 2025, Viz.ai demonstrates strong company stability and a continuous commitment to innovation, recognized by various industry honors.

Investors

Who's funded Viz.ai.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

Healthcare Finance.AI is a company dedicated to leveraging cutting-edge artificial intelligence to optimize healthcare revenue cycles. Their goal is to improve financial outcomes for healthcare providers while simultaneously supporting the industry’s commitment to quality care and efficiency. They aim to achieve this by enhancing healthcare finance through AI innovation, demonstrating increased revenue cycle efficiency, reducing […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School is a global business school that is part of Imperial College London, a top-ranking science-based institution. Established in 2004, the school integrates business and entrepreneurship with technology. Its roots in business education trace back to 1955 with an operational research/management science course. The school is triple-crown accredited (AACSB, AMBA, EQUIS), placing […]

Columbia University, through its online learning initiative ColumbiaX on edX, offers a range of courses, including those focused on healthcare AI. The university is a global leader in research, teaching, and public impact, consistently ranked among top universities. Their online offerings reflect a commitment to academic excellence and expanding access to high-quality education worldwide. For […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.